Investor Presentaiton

2018 Product Launch Plan 33 Type Product Region Indication Brand Regional Marketer Sales WW Sales Generic API Tamsulosin HCI ☐ CN Benign Prostatic Hyperplasia (BPH) Boehringer Ingelheim US$97MM US$1,652.8MM Reversal of Conscious Generic API Flumazenil JP Sedation and General Anesthesia Roche US$13.5MM US$76.1MM Generic ΑΡΙ Capecitabine JP Antineoplastic Roche US$122MM US$834.7MM Generic Drug Oncology Injectable US Myeloid Leukemia MDS US$175.9MM US$284.4MM Generic Fondaparinux US Anti-thrombotic Mylan US$75.1MM US$194.9MM Drug Source: IMS Data (2016Q3-2017Q2) ScinoPharm

View entire presentation